| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA430757
Max Phase: Preclinical
Molecular Formula: C22H26O9
Molecular Weight: 434.44
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C=C(CO)[C@H]1C[C@H](OC(C)=O)[C@@]23O[C@@H]2[C@@H](C[C@]2(C)O[C@H]2c2cc(C)c(o2)[C@@H]1O)OC3=O
Standard InChI: InChI=1S/C22H26O9/c1-9-5-13-18-21(4,30-18)7-14-19-22(31-19,20(26)29-14)15(27-11(3)24)6-12(10(2)8-23)16(25)17(9)28-13/h5,12,14-16,18-19,23,25H,2,6-8H2,1,3-4H3/t12-,14-,15+,16-,18+,19-,21+,22-/m1/s1
Standard InChI Key: VYEIAQHPZWBDHX-NAXQBTESSA-N
Associated Targets(non-human)
Acetylcholine receptor 120 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 434.44 | Molecular Weight (Monoisotopic): 434.1577 | AlogP: 1.40 | #Rotatable Bonds: 3 |
| Polar Surface Area: 131.26 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.15 | CX Basic pKa: | CX LogP: 0.25 | CX LogD: 0.25 |
| Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.41 | Np Likeness Score: 3.32 |
References
| 1. Abramson SN, Trischman JA, Tapiolas DM, Harold EE, Fenical W, Taylor P.. (1991) Structure/activity and molecular modeling studies of the lophotoxin family of irreversible nicotinic receptor antagonists., 34 (6): [PMID:1676426] [10.1021/jm00110a007] |
Source
Source(1):